Green Chemical Co., Ltd.'s (KRX:083420) 25% Share Price Surge Not Quite Adding Up

Green Chemical Co., Ltd. (KRX:083420) shareholders would be excited to see that the share price has had a great month, posting a 25% gain and recovering from prior weakness. Unfortunately, despite the strong performance over the last month, the full year gain of 7.9% isn't as attractive.

After such a large jump in price, Green Chemical may be sending very bearish signals at the moment with a price-to-earnings (or "P/E") ratio of 21.7x, since almost half of all companies in Korea have P/E ratios under 11x and even P/E's lower than 6x are not unusual. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.

We've discovered 2 warning signs about Green Chemical. View them for free.

With earnings growth that's exceedingly strong of late, Green Chemical has been doing very well. The P/E is probably high because investors think this strong earnings growth will be enough to outperform the broader market in the near future. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.

See our latest analysis for Green Chemical

pe-multiple-vs-industry
KOSE:A083420 Price to Earnings Ratio vs Industry April 20th 2025
We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Green Chemical's earnings, revenue and cash flow.
Advertisement

Is There Enough Growth For Green Chemical?

Green Chemical's P/E ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the market.

Taking a look back first, we see that the company grew earnings per share by an impressive 144% last year. Despite this strong recent growth, it's still struggling to catch up as its three-year EPS frustratingly shrank by 49% overall. Accordingly, shareholders would have felt downbeat about the medium-term rates of earnings growth.

In contrast to the company, the rest of the market is expected to grow by 22% over the next year, which really puts the company's recent medium-term earnings decline into perspective.

In light of this, it's alarming that Green Chemical's P/E sits above the majority of other companies. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. There's a very good chance existing shareholders are setting themselves up for future disappointment if the P/E falls to levels more in line with the recent negative growth rates.

The Key Takeaway

The strong share price surge has got Green Chemical's P/E rushing to great heights as well. We'd say the price-to-earnings ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.

Our examination of Green Chemical revealed its shrinking earnings over the medium-term aren't impacting its high P/E anywhere near as much as we would have predicted, given the market is set to grow. When we see earnings heading backwards and underperforming the market forecasts, we suspect the share price is at risk of declining, sending the high P/E lower. If recent medium-term earnings trends continue, it will place shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

Before you settle on your opinion, we've discovered 2 warning signs for Green Chemical (1 is concerning!) that you should be aware of.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSE:A083420

Green Chemical

Produces and sells ethylene oxide adducts (EOA), ethanolamines, dimethyl carbonates, and acrylate monomers in South Korea.

Excellent balance sheet with acceptable track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0768.0% undervalued
284 users have followed this narrative
1 users have commented on this narrative
41 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
90 users have followed this narrative
1 users have commented on this narrative
23 users have liked this narrative
TO
Tokyo
ABI logo
Tokyo on Anheuser-Busch InBev ·

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

Fair Value:€89.4524.2% undervalued
7 users have followed this narrative
3 users have commented on this narrative
3 users have liked this narrative
OS
oscargarcia
AMZN logo
oscargarcia on Amazon.com ·

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.

Fair Value:US$2803.2% undervalued
62 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

TA
Talos
EVAX logo
Talos on Evaxion ·

The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)

Fair Value:US$20.2579.9% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnonymousPlanner
ADBE logo
AnonymousPlanner on Adobe ·

Good Value for a Creative Monopoly

Fair Value:US$317.6619.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CO
composite32
RGYAS logo
composite32 on Ronesans Gayrimenkul Yatirim ·

Investing in the future with RGYAS as fair value hits 228.23

Fair Value:₺313.4139.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.230.7% undervalued
68 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
90 users have followed this narrative
1 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$561.9325.1% undervalued
1396 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative